Essential COPD Medications: Types, Uses, and Safety Guidelines

Chronic obstructive pulmonary disease (COPD) encompasses progressive lung conditions—most commonly emphysema and chronic bronchitis—that make breathing difficult.

Typical COPD symptoms include:

• Shortness of breath
• Persistent cough
• Wheezing
• Chest tightness

In the United Kingdom, the National Health Service (NHS) estimates that smoking accounts for roughly nine‑in‑ten COPD cases.

While COPD is irreversible and has no cure, a range of medications can lessen airway inflammation and widen the passages, helping you breathe more comfortably.

Warnings for COPD medications

Take every prescription exactly as your clinician directs. If you develop a serious allergic reaction—such as rash, swelling of the face, lips, tongue, or throat—seek medical help immediately. Difficulty breathing or swelling of the mouth or throat warrants an emergency call to 911 or your local emergency services.

Because some COPD drugs can affect heart rhythm or blood pressure, inform your doctor about any existing cardiovascular problems before starting treatment.

Bronchodilators (short‑acting)

Short‑acting bronchodilators are the first line for rapid relief. They are delivered via inhaler or nebulizer and work within minutes.

Common rescue inhalers include albuterol (ProAir HFA, Ventolin HFA) and levalbuterol (Xopenex). Daily maintenance options such as ipratropium (Atrovent HFA) and the combination albuterol/ipratropium (Combivent Respimat) are also available.

Possible side effects—typically transient—may include tremor, rapid heartbeat, or mild throat irritation. Patients with known heart disease should discuss these agents with their physician.

Corticosteroids

Inhaled corticosteroids reduce airway inflammation and are usually prescribed alongside a long‑acting bronchodilator for moderate‑to‑severe COPD. Examples are fluticasone, budesonide, and beclomethasone. Oral or injectable corticosteroids are reserved for short courses during acute exacerbations.

Side effects can include oral thrush, hoarse voice, or, rarely, systemic effects such as elevated blood sugar.

Theophylline

Theophylline, a methylxanthine, was once used as an add‑on anti‑inflammatory agent. Because of its narrow therapeutic window and potential for cardiac and neurological toxicity, current guidelines advise against routine use.

Long‑acting bronchodilators

Long‑acting bronchodilators are taken once or twice daily to provide steady airway support and reduce the frequency of flare‑ups. They are not rescue medications.

• LABA (long‑acting beta‑2 agonists): salmeterol (Serevent), formoterol (Foradil, Perforomist), indacaterol (Arcapta)
• LAMA (long‑acting muscarinic antagonists): tiotropium (Spiriva), aclidinium (Tudorza), glycopyrrolate (Seebri Neohaler, Lonhala Magnair)

Side effects may include dry mouth, constipation, or, rarely, urinary retention.

Combination inhalers

Many patients benefit from inhalers that combine two long‑acting agents (LABA + LAMA) or an inhaled corticosteroid with a LABA. The American Thoracic Society (ATS) recommends a LABA/LAMA combo for individuals who experience dyspnea during exercise.

Typical LABA/LAMA combinations include:

• Umeclidinium/vilanterol (Anoro Ellipta)
• Tiotropium/olodaterol (Stiolto Respiratory)

Inhaled corticosteroid + LABA combos include:

• Fluticasone/salmeterol (Advair Diskus)
• Budesonide/formoterol (Symbicort)

Triple therapy

For patients who remain symptomatic despite a LABA/LAMA regimen, adding an inhaled corticosteroid creates “triple therapy.” A 2018 systematic review showed that triple therapy reduces exacerbations and improves lung function, although it modestly increases the risk of pneumonia.

An example is fluticasone/vilanterol/umeclidinium (Trelegy Ellipta).

Roflumilast

Roflumilast (Daliresp) is a phosphodiesterase‑4 inhibitor taken as a once‑daily tablet. It targets inflammation in severe COPD or chronic bronchitis, especially in patients with frequent flare‑ups. Common side effects are weight loss, nausea, and mood changes; liver disease or depression should be discussed with your doctor.

Mucoactive agents

To thin airway mucus, clinicians may prescribe oral agents such as carbocysteine, erdosteine, or N‑acetylcysteine. A 2019 study linked these drugs to fewer exacerbations and reduced disability. Possible adverse effects include gastrointestinal upset.

Vaccinations

Annual influenza vaccination and pneumococcal vaccines are strongly advised for all COPD patients to lower the risk of respiratory infections and subsequent exacerbations.

Antibiotic prophylaxis

Long‑term, low‑dose antibiotics (e.g., azithromycin) have been shown in a 2018 review to decrease exacerbation frequency, though the optimal duration and safety profile remain under investigation.

Emerging therapies

Pre‑clinical research suggests that certain cancer‑targeted agents, such as tyrphostin AG825, can dampen lung inflammation. Early‑stage studies also explore biologic drugs—currently approved for severe asthma—as potential treatments for eosinophilic COPD, though none are approved yet.

What is the most common drug used for COPD?

Short‑acting bronchodilators are the first‑line rescue therapy, according to the NHS.

What are the top 5 inhalers for COPD?

The “best” inhaler depends on individual disease severity, inhaler technique, and comorbidities. Options span short‑acting bronchodilators, long‑acting bronchodilators, inhaled corticosteroids, and fixed‑dose combinations.

What is the new drug for COPD?

Several biologic agents are currently in clinical trials, aiming to address inflammatory pathways not targeted by existing medications.

Because COPD treatment is highly individualized, discuss the following questions with your healthcare provider:

• How often should I use each COPD medication?
• Are there drug‑drug interactions I need to be aware of?
• What is the expected duration of therapy?
• Can you demonstrate the correct inhaler technique?
• What are the risks of abruptly stopping a medication?
• Which lifestyle changes can complement my medication regimen?
• What should I do if my symptoms suddenly worsen?
• How can I minimize side‑effects?

Need help finding a primary‑care physician? Try our FindCare tool.